Amgen Inc.
Long
Updated

$AMGN (NASDAQ) - Buy

35
I don't usually trade biotech, however, AMGEN is looking like a buy to me. Showing rejection from the 200ma with a bullish engulfing bar.

RSI was previously oversold at the 200ma along with the Stoch.

Strong fundamentals. One downgrade from Argus but most ratings still targeting 188-198.

Entry: 175
Stop - 167
TP1 - 188
TP2 - 200
Order cancelled
Buy order not triggered as price failed to break higher. Price now below 200ma, trade invalid.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.